Oklahoma basketball fans are about to see how cruel this season can really get

You think January was bad?
Vasha Hunt-Imagn Images

It's officially been an entire month since the Oklahoma Sooners won a men's basketball game. And that was the easy part.

There is no good or bad news for OU basketball at this point in the season, only bad and worst. It would seem like a good thing the Sooners flipped the calendar to a new month to hopefully move on during an eight-game losing streak, but in the heat of their SEC schedule, January, during which OU went 1-8, was actually the easiest month left for the Sooners.

The Sooners started SEC play and the month of January with a win over Ole Miss, but then dropped the next eight. Of OU's nine conference games so far, five came against teams in the bottom half of the SEC standings, which the Sooners are at the bottom of, and four of those matchups were losses.

Now the worst news: After what should have been an easier slate for the Sooners, according to ESPN's Men's College Basketball Power Index, OU has the toughest remaining schedule in the country. The index projects the Sooners to finish 4.2-13.8 in SEC play.

Sooners have toughest remaining schedule in college basketball

Between February and two games in March, the Sooners have nine games left after getting halfway through their SEC slate. Of those nine games, six are against Quad 1 opponents, and five of those are on the road. The only Quad 2 matchups left for OU include home games against Georgia, Texas A&M and Missouri. Texas A&M and Mizzou both already beat the Sooners during their eight-game skid.

The Sooners start February on Wednesday with a trip to Kentucky, which has former Sooner Otega Oweh, who averaged 27.5 points in two games against his old team last season. On Saturday, the Sooners head to No. 15 Vanderbilt. Other road trips include No. 25 Tennessee, LSU and Texas. OU will host Georgia, Texas A&M, Auburn and Mizzou.

As miserable as the men's basketball season has been already for OU fans, the worst is actually still to come.

Loading recommendations... Please wait while we load personalized content recommendations